Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).

Abstract	Chemotherapy for metastatic melanoma was performed in 80 consecutive evaluable patients. DTIC, BCNU and CCNU produced responses in 28% of patients, alone or in combination with each other. Three of 62 patients treated with DTIC remain free of tumor, off therapy at 18-36 months following objective regression of metastases. Chemotherapy with commercially available drugs continued to be uniformly unsuccessful. DTIC was used successfully in treatment of extensive extracranial disease, including one patient with metastatic melanoma during pregnancy. Cerebral metastases were the sole or major cause of death in 8/9 patients who relapsed following control with DTIC for nine months or longer, and one patient developed a carcinoma of the breast following therapy with DTIC and BCNU. Remission was induced in two patients with intralesional BCG, after prior attempts to control metastases with DTIC and combination chemotherapy.
Authors	G J Hill 2nd, R Ruess, R Berris, G W Philpott, P Parkin
Journal	Annals of surgery (Ann Surg) Vol. 180 Issue 2 Pg. 167-74 (Aug 1974) ISSN: 0003-4932 [Print] United States
PMID	4601984 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References	Amides Antineoplastic Agents Cyclohexanes Imidazoles Nitrosourea Compounds Triazenes Carmustine
Topics	Adult Amides (administration & dosage, therapeutic use) Antineoplastic Agents (administration & dosage, therapeutic use) Brain Neoplasms (drug therapy, mortality, pathology) Carmustine (administration & dosage, therapeutic use) Clinical Trials as Topic Cyclohexanes (administration & dosage, therapeutic use) Drug Therapy, Combination Female Humans Imidazoles (administration & dosage, therapeutic use) Male Melanoma (drug therapy, pathology, radiotherapy) Middle Aged Neoplasm Metastasis Nitrosourea Compounds (administration & dosage, therapeutic use) Pregnancy Pregnancy Complications (drug therapy) Skin Neoplasms (drug therapy, pathology, radiotherapy) Triazenes (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!